Evidence suggests that aberrant BAFF signaling and dysregulated p100/RelB feedback contribute to hyperactive B cells, T cell dysfunction, and in lupus-prone mice and human SLE patients (42–45). Here, NFKB2 is linked to systemic lupus erythematosus.